I agree that this site is using cookies. You can find further informations here.
X
Malimpensa, Leonardo
28  results:
Search for persons X
?
1

Therapeutic choices and disease activity after 2 years of t..:

Schiavetti, Irene ; Signori, Alessio ; Albanese, Angela...
European Journal of Neurology.  31 (2024)  6 - p. , 2024
Link: https://doi.org/10.1111/..
 
?
2

Exploring miRNAs' Based Modeling Approach for Predicting PI..:

Gosetti di Sturmeck, Tommaso ; Malimpensa, Leonardo ; Ferrazzano, Gina...
International Journal of Molecular Sciences.  25 (2024)  12 - p. 6342 , 2024
Link: https://doi.org/10.3390/..
 
?
3

The multidimensional assessment of body representation and ..:

Raimo, Simona ; Ferrazzano, Gina ; Di Vita, Antonella...
Multiple Sclerosis and Related Disorders.  87 (2024)  - p. 105692 , 2024
Link: https://doi.org/10.1016/..
 
?
4

The Impact of Cytomegalovirus Infection on Natural Killer a..:

Perri, Valentina ; Zingaropoli, Maria Antonella ; Pasculli, Patrizia...
Biology.  13 (2024)  3 - p. 154 , 2024
Link: https://doi.org/10.3390/..
 
?
5

Cladribine and ocrelizumab induce differential miRNA profil..:

Arisi, Ivan ; Malimpensa, Leonardo ; Manzini, Valeria...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
6

Neurophysiological and clinical biomarkers of secondary pro..:

Tartaglia, Matteo ; Canevelli, Marco ; Malimpensa, Leonardo...
Frontiers in Neurology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
7

Frailty and relapse activity in multiple sclerosis: A longi..:

Baione, Viola ; Canevelli, Marco ; Belvisi, Daniele...
Multiple Sclerosis and Related Disorders.  72 (2023)  - p. 104603 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Evaluation of BAFF, APRIL and CD40L in Ocrelizumab-Treated ..:

Zingaropoli, Maria Antonella ; Pasculli, Patrizia ; Tartaglia, Matteo...
Biology.  12 (2023)  4 - p. 587 , 2023
Link: https://doi.org/10.3390/..
 
?
9

Neural bases of motor fatigue in multiple sclerosis: A mult..:

Leodori, Giorgio ; Mancuso, Marco ; Maccarrone, Davide...
Neurobiology of Disease.  180 (2023)  - p. 106073 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Cladribine and ocrelizumab induce differential miRNA profil..:

Arisi, Ivan ; Malimpensa, Leonardo ; Manzini, Valeria...
info:eu-repo/semantics/altIdentifier/pmid/38152407.  , 2023
Link: https://hdl.handle.net/1..
 
?
11

Cladribine and ocrelizumab induce differential miRNA profil..:

Ivan Arisi ; Leonardo Malimpensa ; Valeria Manzini...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1234869/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
12

DataSheet_1_Cladribine and ocrelizumab induce differential ..:

Ivan Arisi ; Leonardo Malimpensa ; Valeria Manzini...
doi:10.3389/fimmu.2023.1234869.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
13

DataSheet_1_Cladribine and ocrelizumab induce differential ..:

Ivan Arisi ; Leonardo Malimpensa ; Valeria Manzini...
doi:10.3389/fimmu.2023.1234869.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
14

Cladribine and ocrelizumab induce differential miRNA profil..:

Arisi, Ivan ; Malimpensa, Leonardo ; Manzini, Valeria...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10751352/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
15

Neurophysiological and clinical biomarkers of secondary pro..:

Tartaglia, Matteo ; Canevelli, Marco ; Malimpensa, Leonardo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060628/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
1-15